JP Morgan resumed coverage on SeaWorld Entertainment with a new price target
$SEAS
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
JP Morgan resumed coverage of SeaWorld Entertainment with a rating of Neutral and set a new price target of $57.00 from $67.00 previously